Abstract
Radiolabeled peptides have emerged as an attractive platform for the diagnostic and therapeutic oncology. However, the 11C-radiolabeling of peptides for positron emission tomography (PET) has been poorly explored, owing to the relatively short half-life of carbon-11 (t 1/2 = 20.3 min) and time-consuming multi-step radiochemical reactions. Existing methods have found limited use and are not routinely encountered in the production of radiotracers. Herein, we propose a facile one-step direct 11C-methylation of cysteine residues in peptides using [11C]methyl triflate under ambient temperatures (20 °C) and short reaction times, on the order of seconds. Good regioselectivity of this method was demonstrated by HPLC in a simple peptide (glutathione, GSH) and a more complex test decapeptide (Trp-Tyr-Trp-Ser-Arg-Cys-Lys-Trp-Thr-Gly) bearing multiple nucleophilic sites. In addition, we extend this method towards the synthesis of [11C]Cys(Me)-[Tyr3-octreotate] as a demonstration of applicability for peptides of biological interest. This octreotate derivative was obtained in non-decay-corrected radiochemical yields of 11 ± 2 % (n = 3) with a synthesis time of approx. 30 min.
Similar content being viewed by others
Abbreviations
- PET:
-
Positron emission tomography
- GSH:
-
Glutathione
- SPPS:
-
Solid-phase peptide synthesis
- SST:
-
Somatostatin
- SPECT:
-
Single-photon emission computed tomography
- [11C]MB-CHO:
-
p-[11C]methyoxybenzaldehyde
- HPLC:
-
High-performance liquid chromatography
- [11C]MeOTf:
-
[11C]methyl trifluoromethylsulfonate; [11C]methyl triflate
- Gly-Sar:
-
Glycylsarcosine
- DMS:
-
Dimethyl sulfate
- MMS:
-
Methyl methanesulfonate
- CNSC:
-
Canadian Nuclear Safety Commission
- Fmoc:
-
Fluorenylmethyloxycarbonyl
- HBTU:
-
O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
- DIPEA:
-
N,N-diisopropylethylamine
- DMF:
-
N,N-dimethylformamide
- TFA:
-
Trifluoroacetate; trifluoroacetic acid
- TIPS:
-
Triisopropylsilane
- HRMS:
-
High-resolution mass spectrometry
- MALDI-TOF:
-
Matrix-assisted laser desorption/ionization/time-of-flight
- DMSO:
-
Dimethyl sulfoxide
- GSMe:
-
S-methylglutathione
- RP-HPLC:
-
Reversed-phase high-performance liquid chromatography
- MEK:
-
Methyl ethyl ketone
- MeCN:
-
Acetonitrile
- ndc:
-
Non-decay-corrected
- RCY:
-
Radiochemical yield
- EtOH:
-
Ethanol
References
Ambrosini V, Fani M, Fanti S, Forrer F, Maecke HR (2011) Radiopeptide imaging and therapy in Europe. J Nucl Med 52:42S–55S
Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1982) SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133–1140
Boffa LC, Bolognesi C (1985) Methylating agents: their target amino acids in nuclear proteins. Carcinogenesis 6:1399–1401
De Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, Bakker WH, Smith C, Pauwels S, Krenning EP (2002) Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings. Semin Nucl Med 32:133–140
Decristoforo C, Maina T, Nock B, Gabriel M, Cordopatis P, Moncayo R (2003) 99mTc-Demotate 1: first data in tumour patients—results of a pilot/phase I study. Eur J Nucl Med Mol Imaging 30:1211–1219
Fani M, Maecke HR, Okarvi SM (2012) Radiolabeled peptides: valuable tools for the detection and treatment of cancer. Theranostics 2:481–501
Franzén HM, Ragnarsson U, Någren K, Långström B (1987) 11C-labelling of substance P. Preparation of a homocysteine-containing precursor and its subsequent application in the synthesis of the labelled neuropeptide. J Chem Soc Perkin Trans I:2241–2247
Hartvig P, Någren K, Lundberg PO, Muhr C, Terenius L, Lundqvist H, Lärksfors L, Långström B (1986) Kinetics of four 11C-labelled enkephalin peptides in the brain, pituitary and plasma of Rhesus monkeys. Regul Pept 16:1–13
Heinrikson RL (1970) Selective S-methylation of cysteine in proteins and peptides. Biochem Biophys Res Commun 41:967–972
Henriksen G, Schottelius M, Poethko T, Hauser A, Wolf I, Schwaiger M, Wester H-J (2004) Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET. Eur J Nucl Med Mol Imaging 31:1653–1657
Jewett DM (1992) A simple synthesis of [11C]methyl triflate. Appl Radiat Isot 43:1383–1385
Koukouraki S, Strauss LG, Georgoulias V, Schuhmacher J, Haberkorn U, Karkavitsas N, Dimitrakopoulou-Strauss A (2006) Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 33:460–466
Långström B, Sjöberg S, Ragnarsson U (1981) A rapid and convenient method for specific 11C-labelling of synthetic polypeptides containing methionine. J Label Compd Radiopharm 18:479–487
Laverman P, McBride WJ, Sharkey RM, Eek A, Joosten L, Oyen WJG, Goldenberg DM, Boerman OC (2010) A novel facile method of labeling octreotide with 18F-fluorine. J Nucl Med 51:454–461
Lundqvist H, Tolmachev V (2002) Targeting peptides and positron emission tomography. Biopolymers (Pept Sci) 66:381–392
Marazano C, Maziere M, Berger G, Comar D (1977) Synthesis of methyl iodide-11C and formaldehyde-11C. Int J Appl Radiat Isot 28:49–52
Meisetschläger G, Poethko T, Stahl A, Wolf I, Scheidhauer K, Schottelius M, Herz M, Wester H-J, Schwaiger M (2006) Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide. J Nucl Med 47:566–573
Nabulsi NB, Smith DE, Kilbourn MR (2005) [11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice. Bioorg Med Chem 13:2993–3001
Nakagawa Y, Bender ML (1969) Modification of α-chymotrypsin by methyl p-nitrobenzenesulfonate. J Am Chem Soc 91:1566–1567
Okarvi SM (2004) Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases. Med Res Rev 24:357–397
Rahmim A, Zaidi H (2008) PET versus SPECT: strengths, limitations and challenges. Nucl Med Comm 29:193–207
Reubi J-C (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24:389–427
Roehm PC, Berg JM (1998) Selectivity of methylation of metal-bound cysteinates and its consequences. J Am Chem Soc 120:13083–13087
Rufini V, Calcagni ML, Baum RP (2006) Imaging of neuroendocrine tumors. Semin Nucl Med 36:228–247
Savige WE, Fontana A (1980) Oxidation of tryptophan to oxindolylalanine by dimethyl sulfoxide–hydrochloric acid. Int J Peptide Protein Res 15:285–297
Schottelius M, Poethko T, Herz M, Reubi J-C, Kessler H, Schwaiger M, Wester H-J (2004) First 18F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin Cancer Res 10:3593–3606
Sprague JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ (2004) Preparation and biological evaluation of copper-64-labeled Tyr3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res 10:8674–8682
Tam JP, Wu C-R, Liu W, Zhang J-W (1991) Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications. J Am Chem Soc 113:6657–6662
Wang Q, Graham K, Schauer T, Fietz T, Mohammed A, Liu X, Hoffend J, Haberkorn U, Eisenhut M, Mier W (2004) Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate. Nucl Med Biol 31:21–30
Wängler C, Waser B, Alke A, Iovkova L, Buchholz HG, Niedermoser S, Jurkschat K, Fottner C, Bartenstein P, Schirrmacher R, Reubi J-C, Wester H-J, Wängler B (2010) One-step 18F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET). Bioconjugate Chem 21:2289–2296
Wängler C, Niedermoser S, Chin J, Orchowski K, Schirrmacher E, Jurkschat K, Iovkova-Berends L, Kostikov AP, Schirrmacher R, Wängler B (2012) One-step 18F-labeling of peptides for positron emission tomography imaging using the SiFA methodology. Nat Protoc 7:1946–1955
Weiner RE, Thakur ML (2001) Radiolabeled peptides in diagnosis and therapy. Semin Nucl Med 31:296–311
Wellings DA, Atherton E (1997) [4] Standard Fmoc protocols. Methods Enzymol 289:44–67
Wester H-J, Schottelius M, Scheidhauer K, Meisetschläger G, Herz M, Rau FC, Reubi J-C, Schwaiger M (2003) PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide. Eur J Nucl Med Mol Imaging 30:117–122
Wild D, Mäcke HR, Waser B, Reubi J-C, Ginj M, Rasch H, Müller-Brand J, Hofmann M (2005) 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur J Nucl Med Mol Imaging 32:724
Acknowledgments
This work was financially supported by Canada Foundation for Innovation (CFI) project no. 203639 to R.S.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chin, J., Vesnaver, M., Bernard-Gauthier, V. et al. Direct one-step labeling of cysteine residues on peptides with [11C]methyl triflate for the synthesis of PET radiopharmaceuticals. Amino Acids 45, 1097–1108 (2013). https://doi.org/10.1007/s00726-013-1562-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-013-1562-5